Schering Antifungal "Free" Offers Not Exempt From FTC Rules - NAD
This article was originally published in The Tan Sheet
Schering-Plough's year-round offers of "bonus" sizes of Lotrimin AF and Tinactin topical antifungal products are not exempt from Federal Trade Commission rules regarding the timing of "free" offers, the National Advertising Division of the Council of Better Business Bureaus concludes in its January case report.
You may also be interested in...
Schering-Plough and Playtex should modify product advertising claiming "free" bonus amounts to facilitate third-party evaluation of such promotions, NAD states in its February Case Reports.
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC